Search results
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
The Dispatch via Yahoo News· 5 days agoThe U.S. contracted with AstraZeneca early in the pandemic for the delivery of 300 million doses of...
AstraZeneca aims increase its annual revenue by 75% in its post-COVID era
Quartz· 3 hours agoCambridge, U.K.-based pharmacuetical giant AstraZeneca announced an ambitious sales goal for the end of this decade, just as it pulls it COVID-19 vaccines off the shelves.
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 1 day agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Could Novavax Become the Next Moderna? | The Motley Fool
The Motley Fool· 4 days agoInvestors were betting on the companies' coronavirus vaccine candidates and their ability to bring...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters· 4 days agoModerna said on Friday the European Patent Office had upheld the validity of one of the company's...
Could Novavax Become the Next Moderna?
The Motley Fool via AOL· 4 days agoThe Sanofi agreement even prompted Novavax to say it now no longer is at risk of shutting its doors. But does this mean Novavax could become a leader in...
ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development
Benzinga via Yahoo Finance· 3 hours agoAlso Read: Drugmaker Sanofi’s Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings. Sanofi...
Sanofi (SNY) Signs Deal for AI-Powered Drug Development
Zacks via Yahoo Finance· 1 hour agoWith this deal, MRNA is looking to bring a new generation of medicines to patients in need. Moderna...
Does AI Really Make Moderna Stock (NASDAQ:MRNA) a Buy?
TipRanks via Yahoo Finance· 4 days agoModerna (NASDAQ:MRNA) stock has collapsed from its all-time high. However, the company is once again...
Smart Money Is Betting Big In MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 6 days agoModerna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with ...